These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19300105)

  • 21. Should physicians aggressively treat prehypertension?
    Garrett SL
    Am J Med; 2009 May; 122(5):e19; author reply e21. PubMed ID: 19375537
    [No Abstract]   [Full Text] [Related]  

  • 22. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan-antioxidant hybrids: novel molecules for the prevention of hypertension-induced cardiovascular damage.
    García G; Rodríguez-Puyol M; Alajarín R; Serrano I; Sánchez-Alonso P; Griera M; Vaquero JJ; Rodríguez-Puyol D; Alvarez-Builla J; Díez-Marqués ML
    J Med Chem; 2009 Nov; 52(22):7220-7. PubMed ID: 19863054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic importance of white coat and masked hypertension].
    Gustavsen P; Hansen TW
    Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk prediction in subjects with high-normal blood pressure.
    Schneider MP; Schmieder RE
    J Hypertens; 2009 Jun; 27(6):1126-8. PubMed ID: 19454903
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypertension and intra-operative incidents: a multicentre study of 125,000 surgical procedures in Swiss hospitals.
    Beyer K; Taffé P; Halfon P; Pittet V; Pichard S; Haller G; Burnand B;
    Anaesthesia; 2009 May; 64(5):494-502. PubMed ID: 19413818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concepts guiding therapy for hypertension in children.
    Hanevold CD
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):647-57. PubMed ID: 19505280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension and the heart].
    Wachtell K; Andersen NH; Svendsen TL
    Ugeskr Laeger; 2009 Jun; 171(25):2113-6. PubMed ID: 19671394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular regulation and cardiovascular diseases: what can sleep teach us?
    Castiglioni P; Lombardi C
    J Hypertens; 2009 Aug; 27(8):1533-5. PubMed ID: 19622927
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical impact of adducin polymorphism.
    Bianchi G; Manunta P; Glorioso N
    J Hypertens; 2009 Jun; 27(6):1325-7; author reply 1327-9. PubMed ID: 19454906
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of gas signaling molecule hydrogen sulfide in cardiovascular diseases].
    Wang XB; Jin HF; Du JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):790-3. PubMed ID: 19755041
    [No Abstract]   [Full Text] [Related]  

  • 36. R-wave voltage and cardiovascular risk.
    Clement DL
    J Hypertens; 2009 Aug; 27(8):1538-9. PubMed ID: 19622929
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study.
    Salles GF; Cardoso CR; Muxfeldt ES
    J Hypertens; 2009 May; 27(5):1094-101. PubMed ID: 19390353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2.
    Bommer WJ
    Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blockers for treatment of hypertension.
    Basile JN; Cohen JD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):11-7. PubMed ID: 19667665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk can be represented by scaled rectangle diagrams.
    Marshall RJ
    J Clin Epidemiol; 2009 Sep; 62(9):998-1000. PubMed ID: 19635404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.